NeuroOne CEO Dave Rosa talks uplisting on Nasdaq, upcoming advancements
December 14, 2021 at 16:38 PM EST
NeuroOne commercialized its first diagnostic brain-scan product in January and uplisted to the Nasdaq in May.
Photography by Christophe Tomatis